Cara Therapeutics | CARA - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Alterity Therapeutics Limited AUD 4.57M 1.42M 2025-12
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cassava Sciences USD 117K 3K 2026-03
Chugai Pharma JPY 381.9B 28.96B 2026-06
Cipla INR 62.19B 12.42B 2026-03
Clal Biotechnology ILS 3.75M 186K 2022-12
Compugen USD 2.34M 44K 2026-03
CSL USD 4.32B 1.35B 2025-12
Grifols EUR 1B 285.88M 2025-12
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
J&J USD 22.54B 1.21B 2026-03
Neurocrine Biosciences USD 887M 118.9M 2026-06
Pacira USD 132.42M 6.78M 2026-06
Pfizer USD 16.19B 19M 2026-06
RedHill Biopharma USD 280K 5.07M 2025-12
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12